Call: +7 771 977 66 65, +7 705 421 2277
Sign in or Register
My basket

Astana Biomed Group, an authorized Abcam distributor in Central Asia

Abiomed homepage

  • Categories
    Signal Transduction
    Cancer
    Epigenetics and Nuclear Signaling
    Immunology
    Cell Biology
    Cardiovascular
    Neuroscience
    Tags & Cell Markers
    Kits/ Lysates/ Other
    Developmental Biology
    Microbiology
    Biochemicals
    Secondary antibodies
    Isotype/Loading Controls
    Antibody Arrays
  • About us
  • Partners
  • Contact
    Address

    Saryarka 32, 18, 010000, Astana city, Kazakhstan

    Telephone +7 771 977 66 65, +7 705 421 2277

    Email

    laboratory@ctlab.kz, orders@abiomed.kz

Back to category
Signal Transduction Signaling Pathway G Protein Signaling Small G Proteins Other

Anti-CLNS1A/CLCI antibody (ab227467)

Anti-CLNS1A/CLCI antibody (ab227467)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)

Key features and details

  • Rabbit polyclonal to CLNS1A/CLCI
  • Suitable for: ICC/IF
  • Reacts with: Human
  • Isotype: IgG

You may also be interested in

Product image
Human CRISP3 ELISA Kit (ab213768)
Product image
Recombinant Human HS3ST1 protein (ab171694)
Product image
Anti-CSF-1-R (phospho Y809) antibody (ab59199)
Product image
Anti-MED13L antibody (ab243590)

Overview

  • Product name

    Anti-CLNS1A/CLCI antibody
    See all CLNS1A/CLCI primary antibodies
  • Description

    Rabbit polyclonal to CLNS1A/CLCI
  • Host species

    Rabbit
  • Tested Applications & Species

    Application Species
    ICC/IF
    Human
    See all applications and species data
  • Immunogen

    Recombinant fragment within Human CLNS1A/CLCI (internal sequence). The exact sequence is proprietary.
    Database link: P54105

  • Positive control

    • ICC/IF: A431 cells.
  • General notes

     This product was previously labelled as CLNS1A

     

Properties

  • Form

    Liquid
  • Storage instructions

    Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C long term. Avoid freeze / thaw cycle.
  • Storage buffer

    pH: 7.00
    Preservative: 0.01% Thimerosal (merthiolate)
    Constituents: 1.21% Tris, 0.75% Glycine, 20% Glycerol (glycerin, glycerine)
  • Concentration information loading...
  • Purity

    Immunogen affinity purified
  • Clonality

    Polyclonal
  • Isotype

    IgG
  • Research areas

    • Cardiovascular
    • Blood
    • Other
    • Epigenetics and Nuclear Signaling
    • DNA / RNA
    • RNA Processing
    • Splicing
    • Epigenetics and Nuclear Signaling
    • DNA / RNA
    • RNA Processing
    • Other

Images

  • Immunocytochemistry/ Immunofluorescence - Anti-CLNS1A/CLCI antibody (ab227467)
    Immunocytochemistry/ Immunofluorescence - Anti-CLNS1A/CLCI antibody (ab227467)

    Paraformaldehyde-fixed A431 (human epidermoid carcinoma cell line) cells stained for CLNS1A/CLCI (green) using ab227467 at 1/500 dilution in ICC/IF.

    Counterstain: alpha tubulin filaments (red).

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

Alternative products to Anti-CLNS1A/CLCI antibody (ab227467)

  •  
  • Product image

    Anti-CLNS1A/CLCI antibody - C-terminal (ab196744)

    Applications: WB

  •  
  • Product image

    Anti-CLNS1A/CLCI antibody [2187C2a] (ab53667)

    Applications: WB

  •  
  • Product image

    Anti-CLNS1A/CLCI antibody - C-terminal (ab192907)

    Applications: IHC-P, IP, WB

Clear all

Recently viewed products

  •  
  • Product image

    Anti-NDUFAF1 antibody [EPR2796] (ab79826)

  •  
  • Product image

    Anti-HECTD2 antibody [EPR11554] (ab173572)

  •  
  • Product image

    Anti-Ferritin Light Chain antibody (ab232752)

  •  
  • Product image

    Anti-CAD/BM1 antibody (ab99312)

  •  
  • Product image

    Anti-DPEP1/MDP antibody (ab121380)

  •  
  • Product image

    Anti-MRPL10 antibody (ab229104)

Get resources and offers direct to your inbox Sign up
© 2021 Astana Biomed Group LLP. All rights reserved.